Health News (Reuters)

Centrexion's chili-based painkiller offers relief for 6 months - study

(Reuters) - A synthetic version of a medicine traditionally extracted from chili plant relieved knee pain among osteoarthritis patients for up to six months, data showed, bringing Centrexion Therapeutics a step closer to developing a safe and effective analgesic.

Aspirin linked to higher risk of serious bleeding in the elderly

LONDON (Reuters) - People who are aged 75 or older and take aspirin daily to ward off heart attacks face a significantly elevated risk of serious or even fatal bleeding and should be given heartburn drugs to minimize the danger, a 10-year study has found.

Are drones a fast way to deliver emergency defibrillators?

(Reuters Health) - Drones may be able to rush emergency defibrillators to patients in cardiac arrest faster than traditional emergency medical services (EMS), potentially improving survival odds, a small Swedish experiment suggests.

WHO confirms Congo polio outbreaks in new eradication setback

GENEVA (Reuters) - Democratic Republic of Congo has suffered two separate outbreaks of polio, a debilitating and potentially deadly disease that the world is trying to eradicate, the World Health Organization said on Tuesday.

Irregular sleep tied to worse grades

(Reuters Health) - College students who go to sleep and wake up at different times during the week may be harming their academic performance, according to a U.S. study.

Prenatal fever linked to autism risk

(Reuters Health) - Children born to mothers who experienced fever, especially multiple fevers, during the second trimester of pregnancy are at increased risk for developing autism spectrum disorder (ASD), a new study suggests.

FDA delays rolling out new nutrition facts label

NEW YORK (Reuters) - The U.S. Food & Drug Administration on Tuesday delayed indefinitely implementation of a new nutrition facts label that would enlarge calorie counts, itemize added sugar and bring serving sizes in line with actual average portions.

Science may be able to provide sunless tans

(Reuters Health) - Sun worshippers might someday be able to get a tan without exposing their skin to the harmful ultraviolet (UV) radiation that's responsible for skin cancers, a new study suggests.

Centene to expand Obamacare insurance to three new states in 2018

(Reuters) - Centene Corp, one of the largest players in the Obamacare individual insurance market, said on Tuesday it would expand into three new states in 2018, despite uncertainty over the future of the legislation under President Donald Trump's administration.

Jury quirk in U.S. meningitis outbreak case could bring stiffer sentence

BOSTON (Reuters) - Prosecutors on Monday said a quirk in the trial verdict of a Massachusetts pharmacist cleared of murder for selling fungus-ridden steroids that killed 64 people in 2012 meant that a judge could still consider the murder allegations at his sentencing.

J&J diabetes drug shows heart benefit in large safety study

(Reuters) - Johnson & Johnson's type 2 diabetes drug Invokana significantly reduced the risk of serious heart problems in patients with established heart disease or at elevated risk in a pair of large studies, according to data presented at a medical meeting on Monday.

Bayer, J&J win second U.S. trial over Xarelto bleeding risks

(Reuters) - A federal jury has cleared Bayer AG and Johnson & Johnson of liability in the second trial to stem from thousands of lawsuits blaming injuries on the blood thinner Xarelto, the drug companies said on Monday.

ADHD tied to driver's license delays, crash risks

(Reuters Health) - Adolescents with attention deficit hyperactivity disorder (ADHD) may wait longer than other teens to obtain a driver's license, and they may be at higher risk for accidents once they do start driving, suggests a new study.

Merck to pause two late-stage studies testing Keytruda in myeloma

(Reuters) - Merck & Co said it paused enrolments in two late-stage studies testing its immunotherapy drug, Keytruda, for multiple myeloma, in combination with other therapies, as the U.S. drugmaker looks to better understand more reports of death in the Keytruda groups.

What’s in a name? Maybe a more appealing vegetable

(Reuters Health) - People may be more likely to pile vegetables on their plates when these dishes are served up with seductive names like “sweet sizzlin’ green beans and crispy shallots” than when they’re peddled as health foods, a recent experiment suggests.